1YPY
Crystal Structure of Vaccinia Virus L1 protein
Summary for 1YPY
Entry DOI | 10.2210/pdb1ypy/pdb |
Descriptor | Virion membrane protein (2 entities in total) |
Functional Keywords | vaccinia virus, orthopox, variola virus, smallpox, l1, viral protein |
Biological source | Vaccinia virus |
Cellular location | Virion membrane ; Single-pass membrane protein : P07612 |
Total number of polymer chains | 2 |
Total formula weight | 39065.75 |
Authors | Su, H.P.,Garman, S.C.,Allison, T.J.,Fogg, C.,Moss, B.,Garboczi, D.N. (deposition date: 2005-01-31, release date: 2005-03-01, Last modification date: 2024-10-09) |
Primary citation | Su, H.P.,Garman, S.C.,Allison, T.J.,Fogg, C.,Moss, B.,Garboczi, D.N. The 1.51-Angstrom structure of the poxvirus L1 protein, a target of potent neutralizing antibodies. Proc.Natl.Acad.Sci.Usa, 102:4240-4245, 2005 Cited by PubMed Abstract: Although eradicated from nature more than two decades ago, the threat of smallpox has reemerged because of concerns over its use as a biological weapon. We present the structure of the poxvirus L1 protein, a molecule that is conserved throughout the poxvirus family and is nearly identical in vaccinia virus and in variola virus, which causes smallpox. L1 is a myristoylated envelope protein that is a potent target for neutralizing antibodies and an important component of current experimental vaccines. The L1 structure reveals a hydrophobic cavity located adjacent to its N terminus. The cavity would be capable of shielding the myristate moiety, which is essential for virion assembly. The structure of L1 is a step in the elucidation of molecular mechanisms common to all poxviruses that may stimulate the design of safer vaccines and new antipoxvirus drugs. PubMed: 15761054DOI: 10.1073/pnas.0501103102 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.51 Å) |
Structure validation
Download full validation report